Your browser doesn't support javascript.
loading
Worldwide expert recommendations for the diagnosis and management of vitiligo: Position statement from the International Vitiligo Task Force Part 1: towards a new management algorithm.
van Geel, Nanja; Speeckaert, Reinhart; Taïeb, Alain; Ezzedine, Khaled; Lim, Henry W; Pandya, Amit G; Passeron, Thierry; Wolkerstorfer, Albert; Abdallah, Marwa; Alomar, Augustin; Bae, Jung Min; Bekkenk, Marcel; Benzekri, Laila; Böhm, Markus; Eleftheriadou, Viktoria; Esmat, Samia; Ghia, Deepti; Goh, Boon Kee; Grimes, Pearl; Gupta, Somesh; Hamzavi, Iltefat H; Harris, John E; Oh, Sang Ho; Huggins, Richard; Katayama, Ichiro; Lan, Eric; Lee, Ai-Young; Leone, Giovanni; Le Poole, Caroline; Lui, Harvey; Maquignon, Nicolle; Meurant, Jean Marie; Monteiro, Paul; Oiso, Naoki; Parsad, Davinder; Pliszewski, Georg; Raboobee, Noufal; Rodrigues, Michelle; Rosmarin, David; Suzuki, Tamio; Tanemura, Atsushi; Thng, Steven; Xiang, Flora; Zhou, Youwen; Picardo, Mauro; Seneschal, Julien.
Affiliation
  • van Geel N; Department of Dermatology, Ghent University Hospital, Ghent, Belgium.
  • Speeckaert R; Department of Dermatology, Ghent University Hospital, Ghent, Belgium.
  • Taïeb A; Department of Dermatology and Pediatric Dermatology, National Reference Center for Rare Skin Disorders, Hospital Saint-André, BRIC, UMR 1312, Inserm, University Bordeaux, Bordeaux, France.
  • Ezzedine K; Department of Dermatology, University Hospital Henri Mondor, EpiDermE EA 7379, Université Paris-Est Créteil Val de Marne, Créteil, France.
  • Lim HW; Department of Dermatology, Henry Ford Health, Detroit, Michigan, USA.
  • Pandya AG; Department of Dermatology, The University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Passeron T; Department of Dermatology, University Hospital of Nice, Nice, France.
  • Wolkerstorfer A; Department of Dermatology, Ghent University Hospital, Ghent, Belgium.
  • Abdallah M; Department of Dermatology, Netherlands Institute for Pigment Disorders, Amsterdam University Medical Centers, Amsterdam Institute for Infection and Immunity, University of Amsterdam, Amsterdam, The Netherlands.
  • Alomar A; Dermatology, Andrology, and Venereology Department, Ain Shams University, Cairo, Egypt.
  • Bae JM; Department of Dermatology, Clinica Dermatologica Moragas, Barcelona, Spain.
  • Bekkenk M; Department of Dermatology, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea.
  • Benzekri L; Department of Dermatology, Netherlands Institute for Pigment Disorders, Amsterdam University Medical Centers, Amsterdam Institute for Infection and Immunity, VU University, Amsterdam, The Netherlands.
  • Böhm M; Department of Dermatology, Ibn Sina University Hospital, Mohammed V University, Rabat, Morocco.
  • Eleftheriadou V; Department of Dermatology, University Hospital Münster, Münster, Germany.
  • Esmat S; New Cross Hospital, The Royal Wolverhampton NHS Trust, Wolverhampton, UK.
  • Ghia D; Department of Dermatology, Faculty of Medicine, Cairo University, Cairo, Egypt.
  • Goh BK; Department of Dermatology, Jaslok Hospital and Research Hospital and South Mumbai Dermatology Clinic, Mumbai, India.
  • Grimes P; Skin Physicians Pte Ltd, Mount Elizabeth Medical Centre, Singapore City, Singapore.
  • Gupta S; Vitiligo & Pigmentation Institute of Southern California, Los Angeles, California, USA.
  • Hamzavi IH; Department of Dermatology and Venereology, All India Institute of Medical Sciences, New Delhi, India.
  • Harris JE; Department of Dermatology, Henry Ford Health, Detroit, Michigan, USA.
  • Oh SH; Department of Dermatology, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.
  • Huggins R; Department of Dermatology, Severance Hospital, Cutaneous Biology Research Institute, Yonsei University College of Medicine, Seoul, South Korea.
  • Katayama I; Department of Dermatology, Henry Ford Health, Detroit, Michigan, USA.
  • Lan E; Pigmentation Research and Therapeutics, Osaka Metropolitan University, Osaka, Japan.
  • Lee AY; Department of Dermatology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
  • Leone G; Department of Dermatology, College of Medicine, Dongguk University Ilsan Hospital, Goyang, Korea.
  • Le Poole C; Photodermatology and Vitiligo Treatment Unit, Israelite Hospital, Roma, Italy.
  • Lui H; Departments of Dermatology, Microbiology and Immunology, Robert H. Lurie Comprehensive Cancer Center Northwestern University, Chicago, Illinois, USA.
  • Maquignon N; Department of Dermatology and Skin Science, University of British Columbia, Vancouver, British Columbia, Canada.
  • Meurant JM; Association Française du Vitiligo, Paris, France.
  • Monteiro P; Vitiligo International Patient Organisations Committee, Paris, France.
  • Oiso N; Vitiligo.nl, Den Haag, The Netherlands.
  • Parsad D; Department of Dermatology, Kindai University Nara Hospital, Ikoma, Japan.
  • Pliszewski G; Department of Dermatology, Venereology & Leprology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Raboobee N; Deutscher Vitiligo-Bund e.V., Adelsdorf, Germany.
  • Rodrigues M; Department of Dermatology, Westville Hospital, Durban, South Africa.
  • Rosmarin D; Chroma Dermatology, Pigment and Skin of Colour Centre, Parkville, Victoria, Australia.
  • Suzuki T; Department of Dermatology, The Royal Children's Hospital, Parkville, Victoria, Australia.
  • Tanemura A; Department of Dermatology, Tufts University School of Medicine, Boston, Massachusetts, USA.
  • Thng S; Department of Dermatology, Yamagata University Faculty of Medicine, Yamagata, Japan.
  • Xiang F; Department of Dermatology Integrated Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Zhou Y; Skin Research Institute of Singapore, ASTAR, Singapore City, Singapore.
  • Picardo M; Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China.
  • Seneschal J; Department of Dermatology and Skin Science, University of British Columbia, Vancouver, British Columbia, Canada.
J Eur Acad Dermatol Venereol ; 37(11): 2173-2184, 2023 Nov.
Article in En | MEDLINE | ID: mdl-37746876
ABSTRACT

BACKGROUND:

The treatment of vitiligo can be challenging and depends on several factors such as the subtype, disease activity, vitiligo extent, and treatment goals. Vitiligo usually requires a long-term approach. To improve the management of vitiligo worldwide, a clear and up-to-date guide based on international consensus with uniform stepwise recommendations is needed.

OBJECTIVES:

To reach an international consensus on the nomenclature and to develop a management algorithm for the diagnosis, assessment, and treatment of vitiligo.

METHODS:

In this consensus statement, a consortium of 42 international vitiligo experts and four patient representatives participated in online and live meetings to develop a consensus management strategy for vitiligo. At least two vitiligo experts summarized the evidence of topics included in the algorithms. A survey was utilized to resolve remaining issues among a core group of eight experts. Subsequently, the unanimous recommendations were finalized and validated based on further input from the entire group during two live meetings.

RESULTS:

The algorithms highlight the importance of shared decision-making. Dermatologists are encouraged to provide patients with detailed explanations of the prognosis and expected therapeutic outcomes based on clinical examination. The treatment goal should be discussed and clearly emphasized to patients given the different approaches for disease stabilization and repigmentation. The evaluation of disease activity remains a cornerstone in the tailor-made approach to vitiligo patients.

CONCLUSIONS:

These new treatment algorithms are intended to guide clinical decision-making in clinical practice. Promising novel therapies for vitiligo are on the horizon, further highlighting the need for reliable outcome measurement instruments and greater emphasis on shared decision-making.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vitiligo Type of study: Diagnostic_studies / Guideline / Prognostic_studies / Qualitative_research Limits: Humans Language: En Journal: J Eur Acad Dermatol Venereol Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vitiligo Type of study: Diagnostic_studies / Guideline / Prognostic_studies / Qualitative_research Limits: Humans Language: En Journal: J Eur Acad Dermatol Venereol Year: 2023 Document type: Article